Literature DB >> 19193866

Fibrinogen-induced endothelin-1 production from endothelial cells.

Utpal Sen1, Neetu Tyagi, Phani K Patibandla, William L Dean, Suresh C Tyagi, Andrew M Roberts, David Lominadze.   

Abstract

We previously demonstrated that fibrinogen (Fg) binding to the vascular endothelial intercellular adhesion molecule-1 (ICAM-1) leads to microvascular constriction in vivo and in vitro. Although a role of endothelin-1 (ET-1) in this Fg-induced vasoconstriction was suggested, the mechanism of action was not clear. In the current study, we tested the hypothesis that Fg-induced vasoconstriction results from ET-1 production by vascular endothelial cells (EC) and is mediated by activation of extracellular signal-regulated kinase -1/2 (ERK-1/2). Confluent, rat heart microvascular endothelial cells (RHMECs) were treated with one of the following: Fg (2 or 4 mg/ml), Fg (4 mg/ml) with ERK-1/2 kinase inhibitors (PD-98059 or U-0126), Fg (4 mg/ml) with an antibody against ICAM-1, or medium alone for 45 min. The amount of ET-1 formed and the concentration of released von Willebrand factor (vWF) in the cell culture medium were measured by ELISAs. Fg-induced exocytosis of Weibel-Palade bodies (WPBs) was assessed by immunocytochemistry. Phosphorylation of ERK-1/2 was detected by Western blot analysis. Fg caused a dose-dependent increase in ET-1 formation and release of vWF from the RHMECs. This Fg-induced increase in ET-1 production was inhibited by specific ERK-1/2 kinase inhibitors and by anti-ICAM-1 antibody. Immunocytochemical staining showed that an increase in Fg concentration enhanced exocytosis of WPBs in ECs. A specific endothelin type B receptor blocker, BQ-788, attenuated the enhanced phosphorylation of ERK-1/2 in ECs caused by increased Fg content in the culture medium. The presence of an endothelin converting enzyme inhibitor, SM-19712, slightly decreased Fg-induced phosphorylation of ERK-1/2, but inhibited production of Fg-induced ET-1 production. These results suggest that Fg-induced vasoconstriction may be mediated, in part, by activation of ERK-1/2 signaling and increased production of ET-1 that further increases EC ERK-1/2 signaling. Thus, an increased content of Fg may enhance vasoconstriction through increased production of ET-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193866      PMCID: PMC2670653          DOI: 10.1152/ajpcell.00515.2008

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  55 in total

1.  Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells.

Authors:  Utpal Sen; Karni S Moshal; Neetu Tyagi; Ganesh K Kartha; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2006-12       Impact factor: 6.384

Review 2.  Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease.

Authors:  G D O Lowe
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

3.  Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study.

Authors:  Gunnar Engström; Bo Hedblad; Patrik Tydén; Folke Lindgärde
Journal:  Atherosclerosis       Date:  2008-07-03       Impact factor: 5.162

4.  Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival.

Authors:  E Pluskota; S E D'Souza
Journal:  Eur J Biochem       Date:  2000-08

Review 5.  Endothelin-1: the yin and yang on vascular function.

Authors:  Flora Linda Marasciulo; Monica Montagnani; Maria Assunta Potenza
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 6.  Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.

Authors:  Rhian M Touyz
Journal:  Exp Physiol       Date:  2005-05-12       Impact factor: 2.969

7.  Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.

Authors:  Jared D Sturgeon; Aaron R Folsom; W T Longstreth; Eyal Shahar; Wayne D Rosamond; Mary Cushman
Journal:  Stroke       Date:  2008-06-05       Impact factor: 7.914

8.  Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells.

Authors:  Utpal Sen; Neetu Tyagi; Munish Kumar; Karni S Moshal; Walter E Rodriguez; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2007-09-13       Impact factor: 4.249

Review 9.  Role of inflammation in diabetic nephropathy.

Authors:  Alessia Fornoni; Adeel Ijaz; Thor Tejada; Oliver Lenz
Journal:  Curr Diabetes Rev       Date:  2008-02

10.  Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism.

Authors:  John H Boyd; Edmond H Chau; Chiho Tokunanga; Ryon M Bateman; Greg Haljan; Ehsan Y Davani; Yinjin Wang; Keith R Walley
Journal:  Crit Care       Date:  2008-01-03       Impact factor: 9.097

View more
  27 in total

1.  Pro-inflammatory effect of fibrinogen on vascular smooth muscle cells by regulating the expression of PPARα, PPARγ and MMP-9.

Authors:  Shuyue Wang; Juntian Liu; D I Wu; Xiaoming Pang; Jingjing Zhao; Xiaolu Zhang
Journal:  Biomed Rep       Date:  2015-05-04

2.  Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo.

Authors:  Cecilia Nigro; Gregory A Raciti; Alessia Leone; Thomas H Fleming; Michele Longo; Immacolata Prevenzano; Francesca Fiory; Paola Mirra; Vittoria D'Esposito; Luca Ulianich; Peter P Nawroth; Pietro Formisano; Francesco Beguinot; Claudia Miele
Journal:  Diabetologia       Date:  2014-04-24       Impact factor: 10.122

3.  Hyperfibrinogenemia-mediated astrocyte activation.

Authors:  Vincent D Clark; Ailey Layson; Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Brain Res       Date:  2018-08-25       Impact factor: 3.252

4.  Fibrinogen-induced increased pial venular permeability in mice.

Authors:  Nino Muradashvili; Natia Qipshidze; Charu Munjal; Srikanth Givvimani; Richard L Benton; Andrew M Roberts; Suresh C Tyagi; David Lominadze
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-12       Impact factor: 6.200

Review 5.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

6.  Fibrinogen alters mouse brain endothelial cell layer integrity affecting vascular endothelial cadherin.

Authors:  Nino Muradashvili; Neetu Tyagi; Reeta Tyagi; Charu Munjal; David Lominadze
Journal:  Biochem Biophys Res Commun       Date:  2011-09-02       Impact factor: 3.575

7.  Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction.

Authors:  Natia Qipshidze; Neetu Tyagi; Naira Metreveli; David Lominadze; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-18       Impact factor: 4.733

Review 8.  Vascular and non-vascular contributors to memory reduction during traumatic brain injury.

Authors:  Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Eur J Neurosci       Date:  2019-03-12       Impact factor: 3.386

9.  Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.

Authors:  Nino Muradashvili; Richard L Benton; Kathryn E Saatman; Suresh C Tyagi; David Lominadze
Journal:  Metab Brain Dis       Date:  2014-04-29       Impact factor: 3.584

10.  Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening.

Authors:  Luise Holzhauser; Ronald Zolty
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.